{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T10:22:03Z","timestamp":1778235723987,"version":"3.51.4"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.prp.2024.155231","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T11:00:29Z","timestamp":1709118029000},"page":"155231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Patient-derived melanoma models"],"prefix":"10.1016","volume":"259","author":[{"given":"Franziska","family":"Karras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2024.155231_bib1","unstructured":"Melanoma of the Skin - Cancer Stat Facts, 2023. \u3008https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html\u3009 (accessed 23 October 2023)."},{"key":"10.1016\/j.prp.2024.155231_bib2","unstructured":"Melanoma Skin Cancer Statistics, 2023. \u3008https:\/\/www.cancer.org\/cancer\/types\/melanoma-skin-cancer\/about\/key-statistics.html\u3009 (accessed 23 October 2023)."},{"key":"10.1016\/j.prp.2024.155231_bib3","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA: A Cancer J. Clin."},{"key":"10.1016\/j.prp.2024.155231_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2014.11.001","article-title":"Skin cancer and new treatment perspectives: a review","volume":"357","author":"Sim\u00f5es","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2024.155231_bib5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","article-title":"Melanoma","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2024.155231_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5114\/pdia.2013.33376","article-title":"Skin melanocytes: biology and development","volume":"30","author":"Cichorek","year":"2013","journal-title":"Post. Dermatol. Alergol."},{"key":"10.1016\/j.prp.2024.155231_bib7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/oxfordjournals.jbchem.a127360","article-title":"The reciprocal relationship between melanization and tyrosinase activity in melanosomes (melanin granules)","volume":"49","author":"Seiji","year":"1961","journal-title":"J. Biochem."},{"key":"10.1016\/j.prp.2024.155231_bib8","unstructured":"The\u00a0cancer genome atlas network, genomic classification of cutaneous melanoma,\u00a0Cell\u00a0161\u00a0(2015)\u00a01681\u20131696,\u00a010.1016\/j.cell.2015.05.044. 2015."},{"key":"10.1016\/j.prp.2024.155231_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.prp.2024.155231_bib10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2024.155231_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ccr.2004.09.022","article-title":"Guilty as charged: B-RAF is a human oncogene","volume":"6","author":"Garnett","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2024.155231_bib12","first-page":"29","article-title":"BRAF, MEK and KIT inhibitors for melanoma: adverse events and their management","volume":"3","author":"Livingstone","year":"2014","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155231_bib13","doi-asserted-by":"crossref","first-page":"28087","DOI":"10.1074\/jbc.M112.377218","article-title":"Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)\/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma","volume":"287","author":"Yadav","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2024.155231_bib14","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(12)70413-8","article-title":"Cutaneous toxicities of RAF inhibitors","volume":"14","author":"Anforth","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2024.155231_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature08833","article-title":"RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth","volume":"464","author":"Hatzivassiliou","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.prp.2024.155231_bib16","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S1470-2045(16)30122-X","article-title":"Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial","volume":"17","author":"Ascierto","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2024.155231_bib17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(15)60898-4","article-title":"Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial","volume":"386","author":"Long","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2024.155231_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2024.155231_bib19","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1038\/s41388-018-0171-x","article-title":"Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations","volume":"37","author":"Dankner","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2024.155231_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1470-2045(18)30142-6","article-title":"Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF -mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial","volume":"19","author":"Dummer","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2024.155231_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154788","article-title":"MEK inhibition induces expression of differentiation marker Keratin 10 in human keratinocytes","volume":"250","author":"Karras","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2024.155231_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1470-2045(17)30171-7","article-title":"Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial","volume":"18","author":"Schreuer","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2024.155231_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11912-015-0485-6","article-title":"Molecular targeted therapy approaches for BRAF wild-type melanoma","volume":"18","author":"Johnpulle","year":"2016","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.prp.2024.155231_bib24","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","article-title":"Immune checkpoint inhibitors in melanoma","volume":"398","author":"Carlino","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2024.155231_bib25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/14712598.2022.2038132","article-title":"Immune checkpoint inhibitors for the treatment of melanoma","volume":"22","author":"Sabbatino","year":"2022","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.prp.2024.155231_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41598-018-37188-0","article-title":"Induced cross-resistance of BRAFV600E melanoma cells to standard chemotherapeutic dacarbazine after chronic PLX4032 treatment","volume":"9","author":"Erdmann","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2024.155231_bib27","doi-asserted-by":"crossref","DOI":"10.14440\/jbm.2020.323","article-title":"Real time visualization of cancer cell death, survival and proliferation using fluorochrome-transfected cells in an IncuCyte\u00ae imaging system","volume":"7","author":"Lanigan","year":"2020","journal-title":"J. Biol. Methods"},{"key":"10.1016\/j.prp.2024.155231_bib28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1582-4934.2010.01013.x","article-title":"Discrepancies between metabolic activity and DNA content as tool to assess cell proliferation in cancer research","volume":"14","author":"Quent","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.prp.2024.155231_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-0716-1205-7_4","article-title":"Wound Healing Assay for Melanoma Cell Migration","volume":"2265","author":"Freitas","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.prp.2024.155231_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fcell.2019.00107","article-title":"In Vitro Cell Migration, Invasion, and Adhesion Assays: from Cell Imaging to Data analysis","volume":"7","author":"Pijuan","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.prp.2024.155231_bib31","first-page":"9","article-title":"Diagnostic and prognostic biomarkers in melanoma: current state of play","volume":"7","author":"Utikal","year":"2014","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"10.1016\/j.prp.2024.155231_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-3-642-19022-3_8","article-title":"Chemosensitivity testing in malignant melanoma","volume":"161","author":"Ugurel","year":"2003","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.prp.2024.155231_bib33","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1158\/1078-0432.CCR-05-2763","article-title":"In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group","volume":"12","author":"Ugurel","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2024.155231_bib34","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1038\/srep03751","article-title":"An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models","volume":"4","author":"Celli","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2024.155231_bib35","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nrc4015","article-title":"Precision medicine for cancer with next-generation functional diagnostics","volume":"15","author":"Friedman","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2024.155231_bib36","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.18632\/oncotarget.14443","article-title":"Investigating the utility of human melanoma cell lines as tumour models","volume":"8","author":"Vincent","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155231_bib37","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1158\/0008-5472.CAN-14-0813","article-title":"Direct chemosensitivity monitoring ex vivo on undissociated melanoma tumor tissue by impedance spectroscopy","volume":"74","author":"Jahnke","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2024.155231_bib38","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/jcb.21204","article-title":"Microenvironmental influences in melanoma progression","volume":"101","author":"Lee","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.prp.2024.155231_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/1547691X.2012.723767","article-title":"Microenvironment and tumor progression of melanoma: new therapeutic prospectives","volume":"10","author":"Botti","year":"2013","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.prp.2024.155231_bib40","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm879","article-title":"Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation","volume":"9","author":"Brown","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2024.155231_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246244","article-title":"A novel and effective method for human primary skin melanocytes and metastatic melanoma cell isolation","volume":"13","author":"\u015acie\u017cy\u0144ska","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2024.155231_bib42","doi-asserted-by":"crossref","DOI":"10.3791\/53486","article-title":"Imaging- and flow cytometry-based analysis of cell position and the cell cycle in 3D melanoma spheroids","author":"Beaumont","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.prp.2024.155231_bib43","doi-asserted-by":"crossref","first-page":"16948","DOI":"10.18632\/oncotarget.7659","article-title":"Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity","volume":"7","author":"Raghavan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155231_bib44","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.bios.2008.01.003","article-title":"Microcavity array (MCA)-based biosensor chip for functional drug screening of 3D tissue models","volume":"23","author":"Kloss","year":"2008","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.prp.2024.155231_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bios.2018.08.049","article-title":"A multidimensional impedance platform for the real-time analysis of single and combination drug pharmacology in patient-derived viable melanoma models","volume":"123","author":"Seidel","year":"2019","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.prp.2024.155231_bib46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12885-019-5606-4","article-title":"A novel spheroid-based co-culture model mimics loss of keratinocyte differentiation, melanoma cell invasion, and drug-induced selection of ABCB5-expressing cells","volume":"19","author":"Klicks","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2024.155231_bib47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-1-0716-1205-7_13","article-title":"Preparation, drug treatment, and immunohistological analysis of tri-culture spheroid 3D melanoma-like models","volume":"2265","author":"Sch\u00e4fer","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.prp.2024.155231_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/srep19103","article-title":"3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained","volume":"6","author":"Zanoni","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2024.155231_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17460441.3.1.1","article-title":"In vitro three-dimensional tumor microenvironment models for anticancer drug discovery","volume":"3","author":"Smalley","year":"2008","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.prp.2024.155231_bib50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11626-022-00685-8","article-title":"Spheroid culture models adequately imitate distinctive features of the renal cancer or melanoma microenvironment","volume":"58","author":"Filipiak-Duliban","year":"2022","journal-title":"Vitr. Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.prp.2024.155231_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212200","article-title":"3D cell culture systems: tumor application, advantages, and disadvantages","volume":"22","author":"Habanjar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155231_bib52","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11095-008-9801-2","article-title":"PEG hydrogels for the controlled release of biomolecules in regenerative medicine","volume":"26","author":"Lin","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.prp.2024.155231_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/2211-5463.13719","article-title":"Three-dimensional, PEG-based hydrogels induce spheroid formation and enhance viability of A2058 melanoma cells","author":"Enyedi","year":"2023","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.prp.2024.155231_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2022.130183","article-title":"Melanoma growth in non-chemically modified translucid bacterial nanocellulose hollow and compartimentalized spheres","volume":"1866","author":"Fucina","year":"2022","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.prp.2024.155231_bib55","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73020","article-title":"Quantitative analysis of tumour spheroid structure","volume":"10","author":"Browning","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.prp.2024.155231_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1741-7007-10-29","article-title":"Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation","volume":"10","author":"Vinci","year":"2012","journal-title":"BMC Biol."},{"key":"10.1016\/j.prp.2024.155231_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11153-9","article-title":"Oxygen mapping of melanoma spheroids using small molecule platinum probe and phosphorescence lifetime imaging microscopy","volume":"7","author":"Raza","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2024.155231_bib58","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1016\/j.febslet.2007.08.038","article-title":"Use of multicellular tumor spheroids to dissect endothelial cell-tumor cell interactions: a role for T-cadherin in tumor angiogenesis","volume":"581","author":"Ghosh","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.prp.2024.155231_bib59","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jcp.20320","article-title":"Three-dimensional culture of melanoma cells profoundly affects gene expression profile: a high density oligonucleotide array study","volume":"204","author":"Ghosh","year":"2005","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2024.155231_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050759","article-title":"3D spheroid configurations are possible indictors for evaluating the pathophysiology of melanoma cell lines","volume":"12","author":"Ohguro","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.prp.2024.155231_bib61","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12885-019-5606-4","article-title":"A novel spheroid-based co-culture model mimics loss of keratinocyte differentiation, melanoma cell invasion, and drug-induced selection of ABCB5-expressing cells","volume":"19","author":"Klicks","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2024.155231_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cells11061026","article-title":"3D melanoma cocultures as improved models for nanoparticle-mediated delivery of RNA to tumors","volume":"11","author":"Sch\u00e4fer","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.prp.2024.155231_bib63","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.21873\/anticanres.16290","article-title":"Phenotypic switch and growth of melanoma spheroids in the presence of mast cells: potential impact of nutrient-starvation effects","volume":"43","author":"Grujic","year":"2023","journal-title":"Anticancer Res"},{"key":"10.1016\/j.prp.2024.155231_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.814","article-title":"Preclinical platforms to study therapeutic efficacy of human \u03b3\u03b4 T cells","volume":"12","author":"Ou","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.prp.2024.155231_bib65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.elstat.2007.11.005","article-title":"Electrical impedance spectroscopy study of biological tissues","volume":"66","author":"Dean","year":"2008","journal-title":"J. Electrost."},{"key":"10.1016\/j.prp.2024.155231_bib66","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00216-008-1970-7","article-title":"The use of electrochemical impedance spectroscopy for biosensing","volume":"391","author":"Lisdat","year":"2008","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.prp.2024.155231_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50326-6","article-title":"Electrochemical live monitoring of tumor cell migration out of micro-tumors on an innovative multiwell high-dense microelectrode array","volume":"9","author":"Jahnke","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2024.155231_bib68","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1039\/C0AN00609B","article-title":"High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array","volume":"136","author":"Tung","year":"2011","journal-title":"Analyst"},{"key":"10.1016\/j.prp.2024.155231_bib69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nprot.2008.226","article-title":"Spheroid-based drug screen: considerations and practical approach","volume":"4","author":"Friedrich","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.prp.2024.155231_bib70","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1021\/acsomega.1c05361","article-title":"Proteomic changes in the monolayer and spheroid melanoma cell models of acquired resistance to BRAF and MEK1\/2 inhibitors","volume":"7","author":"Martinez","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.prp.2024.155231_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101408","article-title":"Fine-needle aspiration-based patient-derived cancer organoids","volume":"23","author":"Vilgelm","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.prp.2024.155231_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104614","article-title":"Patient-derived melanoma organoid models facilitate the assessment of immunotherapies","volume":"92","author":"Ou","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.prp.2024.155231_bib73","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.prp.2024.155231_bib74","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.prp.2024.155231_bib75","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1245\/s10434-019-08143-8","article-title":"Model of patient-specific immune-enhanced organoids for immunotherapy screening: feasibility study","volume":"27","author":"Votanopoulos","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.prp.2024.155231_bib76","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/s41416-020-0840-8","article-title":"Alternative macrophage polarisation associated with resistance to anti-PD1 blockade is possibly supported by the splicing of FKBP51 immunophilin in melanoma patients","volume":"122","author":"Troiani","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2024.155231_bib77","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1158\/2159-8290.CD-17-0833","article-title":"Ex vivo profiling of PD-1 blockade using organotypic tumor spheroids","volume":"8","author":"Jenkins","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.prp.2024.155231_bib78","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.prp.2024.155231_bib79","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.prp.2024.155231_bib80","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.3754","article-title":"Quantitative comparison of the spreading and invasion of radial growth phase and metastatic melanoma cells in a three-dimensional human skin equivalent model","volume":"5","author":"Haridas","year":"2017","journal-title":"PeerJ"},{"key":"10.1016\/j.prp.2024.155231_bib81","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9440(10)64719-0","article-title":"Human melanoma progression in skin reconstructs biological significance of bFGF","volume":"156","author":"Meier","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2024.155231_bib82","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1158\/1535-7163.MCT-15-0394","article-title":"A novel fully humanized 3D skin equivalent to model early melanoma invasion","volume":"14","author":"Hill","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.prp.2024.155231_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.249","article-title":"Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing","volume":"4","author":"V\u00f6rsmann","year":"2013","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.prp.2024.155231_bib84","article-title":"Human skin equivalent as an alternative to animal testing","author":"Mertsching","year":"2008","journal-title":"GMS Krank Interdiszip."},{"key":"10.1016\/j.prp.2024.155231_bib85","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1755-148X.2010.00786.x","article-title":"Artificial skin in perspective: concepts and applications","volume":"24","author":"Brohem","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.prp.2024.155231_bib86","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00262-020-02626-4","article-title":"Micro-environmental cross-talk in an organotypic human melanoma-in-skin model directs M2-like monocyte differentiation via IL-10","volume":"69","author":"Michielon","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.prp.2024.155231_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102849","article-title":"A reconstructed human melanoma-in-skin model to study immune modulatory and angiogenic mechanisms facilitating initial melanoma growth and invasion","volume":"15","author":"Michielon","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2024.155231_bib88","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1073\/pnas.0711741105","article-title":"Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity","volume":"105","author":"Tsai","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.prp.2024.155231_bib89","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1755-148X.2010.00763.x","article-title":"PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas","volume":"23","author":"Lee","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.prp.2024.155231_bib90","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1038\/s41467-020-16583-0","article-title":"The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture","volume":"11","author":"Di Blasio","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2024.155231_bib91","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/2159-8290.CD-18-0193","article-title":"Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility","volume":"9","author":"Kaur","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.prp.2024.155231_bib92","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.taap.2015.05.017","article-title":"MUTZ-3 derived Langerhans cells in human skin equivalents show differential migration and phenotypic plasticity after allergen or irritant exposure","volume":"287","author":"Kosten","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.prp.2024.155231_bib93","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/mabi.201200262","article-title":"In vitro 3D full-thickness skin-equivalent tissue model using silk and collagen biomaterials","volume":"12","author":"Bellas","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.prp.2024.155231_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31502-6","article-title":"Tissue-engineered 3D melanoma model with blood and lymphatic capillaries for drug development","volume":"8","author":"Bourland","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2024.155231_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143535","article-title":"3D bioprinting: an enabling technology to understand melanoma","volume":"14","author":"Fernandes","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2024.155231_bib96","doi-asserted-by":"crossref","first-page":"15006","DOI":"10.1088\/1758-5090\/9\/1\/015006","article-title":"3D bioprinting of functional human skin: production and in vivo analysis","volume":"9","author":"Cubo","year":"2016","journal-title":"Biofabrication"},{"key":"10.1016\/j.prp.2024.155231_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101295","article-title":"Tumor cells develop defined cellular phenotypes after 3D-bioprinting in different Bioinks","volume":"8","author":"Schmidt","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.prp.2024.155231_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030589","article-title":"3D-printed collagen scaffolds promote maintenance of cryopreserved patients-derived melanoma explants","volume":"10","author":"Jeong","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.prp.2024.155231_bib99","article-title":"Blood-lymphatic integrated system with heterogeneous melanoma spheroids via in-bath three-dimensional bioprinting for modelling of combinational targeted therapy","volume":"9","author":"Cho","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.prp.2024.155231_bib100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214569119","article-title":"Microfluidics guided by deep learning for cancer immunotherapy screening","volume":"119","author":"Ao","year":"2022","journal-title":"PNAS"},{"key":"10.1016\/j.prp.2024.155231_bib101","doi-asserted-by":"crossref","DOI":"10.3791\/62353-v","article-title":"Generation of a simplified three-dimensional skin-on-a-chip model in a micromachined microfluidic platform","author":"Risue\u00f1o","year":"2021","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.prp.2024.155231_bib102","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.mattod.2017.11.002","article-title":"Full-thickness human skin-on-chip with enhanced epidermal morphogenesis and barrier function","volume":"21","author":"Sriram","year":"2018","journal-title":"Mater. Today"},{"key":"10.1016\/j.prp.2024.155231_bib103","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1039\/D3AN00959A","article-title":"A layered cancer-on-a-chip system for anticancer drug screening and disease modeling","volume":"148","author":"Flont","year":"2023","journal-title":"Analyst"},{"key":"10.1016\/j.prp.2024.155231_bib104","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1039\/D0LC00988A","article-title":"Microfluidic model with air-walls reveals fibroblasts and keratinocytes modulate melanoma cell phenotype, migration, and metabolism","volume":"21","author":"Ayuso","year":"2021","journal-title":"Lab Chip"},{"key":"10.1016\/j.prp.2024.155231_bib105","article-title":"Fibroblasts Impair Migration and Antitumor Activity of NK-92 Lymphocytes in a Melanoma-on-Chip Model","volume":"10","author":"Iaia","year":"2022","journal-title":"Bioeng. (Basel)"},{"key":"10.1016\/j.prp.2024.155231_bib106","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1039\/C8LC00322J","article-title":"3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade","volume":"18","author":"Aref","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.prp.2024.155231_bib107","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jid.2016.08.024","article-title":"Combining Type I interferons and 5-Aza-2\u2032-deoxycitidine to improve anti-tumor response against melanoma","volume":"137","author":"Lucarini","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.prp.2024.155231_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/srep31589","article-title":"3D microtumors in vitro supported by perfused vascular networks","volume":"6","author":"Sobrino","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2024.155231_bib109","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.1073\/pnas.1715932115","article-title":"Inflamed neutrophils sequestered at entrapped tumor cells via chemotactic confinement promote tumor cell extravasation","volume":"115","author":"Chen","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.prp.2024.155231_bib110","article-title":"A dynamic in vivo-like organotypic blood-brain barrier model to probe metastatic brain tumors","volume":"6","author":"Xu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2024.155231_bib111","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.tibtech.2020.11.014","article-title":"Multiorgan-on-a-chip: a systemic approach to model and decipher inter-organ communication","volume":"39","author":"Picollet-D\u2032hahan","year":"2021","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.prp.2024.155231_bib112","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/pcmr.12274","article-title":"Real-time cell cycle imaging during melanoma growth, invasion, and drug response","volume":"27","author":"Haass","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.prp.2024.155231_bib113","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2007.12.033","article-title":"Visualizing spatiotemporal dynamics of multicellular cell-cycle progression","volume":"132","author":"Sakaue-Sawano","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.prp.2024.155231_bib114","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s42003-022-03018-3","article-title":"Designing and interpreting 4D tumour spheroid experiments","volume":"5","author":"Murphy","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.prp.2024.155231_bib115","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2021.0903","article-title":"A stochastic mathematical model of 4D tumour spheroids with real-time fluorescent cell cycle labelling","volume":"19","author":"Klowss","year":"2022","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.prp.2024.155231_bib116","doi-asserted-by":"crossref","first-page":"FSO190","DOI":"10.4155\/fsoa-2017-0003","article-title":"Ex vivo tumor culture systems for functional drug testing and therapy response prediction","volume":"3","author":"Meijer","year":"2017","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.prp.2024.155231_bib117","article-title":"Precision-cut tumor slices (PCTS) as an ex vivo model in immunotherapy research","volume":"11","author":"Dimou","year":"2022","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.prp.2024.155231_bib118","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41416-019-0672-6","article-title":"Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery","volume":"122","author":"Powley","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2024.155231_bib119","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav7171","article-title":"MDM2 antagonists overcome intrinsic resistance to CDK4\/6 inhibition by inducing p21","volume":"11","author":"Vilgelm","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.prp.2024.155231_bib120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095723","article-title":"Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds","volume":"9","author":"Behr","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.prp.2024.155231_bib121","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/jid.2012.459","article-title":"Chemovirotherapy of malignant melanoma with a targeted and armed oncolytic measles virus","volume":"133","author":"Kaufmann","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.prp.2024.155231_bib122","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/17460441.2016.1216968","article-title":"Patient-derived tumor xenograft models for melanoma drug discovery","volume":"11","author":"Harris","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.prp.2024.155231_bib123","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41467-021-27678-7","article-title":"Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment","volume":"13","author":"Sun","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2024.155231_bib124","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.15252\/emmm.201404914","article-title":"Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts","volume":"7","author":"Kemper","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.prp.2024.155231_bib125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41588-020-00750-6","article-title":"Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts","volume":"53","author":"Woo","year":"2021","journal-title":"Nat. Genet"},{"key":"10.1016\/j.prp.2024.155231_bib126","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.18632\/oncotarget.7044","article-title":"Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155231_bib127","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood-2007-11-121319","article-title":"Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model","volume":"111","author":"Tonomura","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.prp.2024.155231_bib128","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41467-017-00786-z","article-title":"Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model","volume":"8","author":"Jespersen","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2024.155231_bib129","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.annonc.2019.11.002","article-title":"Supporting clinical decision making in advanced melanoma by preclinical testing in personalized immune-humanized xenograft mouse models","volume":"31","author":"Ny","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2024.155231_bib130","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1158\/1078-0432.CCR-15-1762","article-title":"Personalized preclinical trials in BRAF inhibitor-resistant patient-derived xenograft models identify second-line combination therapies","volume":"22","author":"Krepler","year":"2016","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.prp.2024.155231_bib131","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.celrep.2017.10.021","article-title":"A comprehensive patient-derived xenograft collection representing the heterogeneity of melanoma","volume":"21","author":"Krepler","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.prp.2024.155231_bib132","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1038\/s41388-021-01911-5","article-title":"Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma","volume":"40","author":"Wang","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2024.155231_bib133","article-title":"Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas","author":"Rebecca","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.prp.2024.155231_bib134","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1158\/2159-8290.CD-22-0787","article-title":"Blocking genomic instability prevents acquired resistance to mapk inhibitor therapy in melanoma","volume":"13","author":"Dharanipragada","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.prp.2024.155231_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030648","article-title":"Treatment with anti-HER2 chimeric antigen receptor tumor-infiltrating lymphocytes (CAR-TILs) is safe and associated with antitumor efficacy in mice and companion dogs","volume":"15","author":"Forsberg","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2024.155231_bib136","first-page":"1225","article-title":"Genomic comparison between an in vitro three-dimensional culture model of melanoma and the original primary tumor","volume":"315","author":"Kim","year":"2023","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.prp.2024.155231_bib137","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2120617119","article-title":"Loss of glucose 6-phosphate dehydrogenase function increases oxidative stress and glutaminolysis in metastasizing melanoma cells","volume":"119","author":"Aurora","year":"2022","journal-title":"PNAS"},{"key":"10.1016\/j.prp.2024.155231_bib138","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-019-1847-2","article-title":"Metabolic heterogeneity confers differences in melanoma metastatic potential","volume":"577","author":"Tasdogan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.prp.2024.155231_bib139","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","article-title":"Lymph protects metastasizing melanoma cells from ferroptosis","volume":"585","author":"Ubellacker","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.prp.2024.155231_bib140","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature17161","article-title":"Melanoma addiction to the long non-coding RNA SAMMSON","volume":"531","author":"Leucci","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.prp.2024.155231_bib141","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/0008-5472.CAN-21-2062","article-title":"A short isoform of spermatogenic enzyme GAPDHS functions as a metabolic switch and limits metastasis in melanoma","volume":"82","author":"Gill","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2024.155231_bib142","doi-asserted-by":"crossref","first-page":"23801","DOI":"10.18632\/oncotarget.8181","article-title":"Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived xenografts","volume":"7","author":"Bhadury","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155231_bib143","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/bjc.1981.276","article-title":"Do cell lines in vitro reflect the properties of the tumours of origin? A study of lines derived from human melanoma xenografts","volume":"44","author":"Tveit","year":"1981","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2024.155231_bib144","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3390\/v7042014","article-title":"Frequent infection of human cancer xenografts with murine endogenous retroviruses in vivo","volume":"7","author":"Naseer","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.prp.2024.155231_bib145","first-page":"166","article-title":"Procedure for horizontal transfer of patient-derived xenograft tumors to eliminate corynebacterium","volume":"56","author":"Manuel","year":"2017","journal-title":"bovis, J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.prp.2024.155231_bib146","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.1016\/S2589-7500(22)00023-1","article-title":"Artificial intelligence and machine learning algorithms for early detection of skin cancer in community and primary care settings: a systematic review","volume":"4","author":"Jones","year":"2022","journal-title":"Lancet Digit. Health"},{"key":"10.1016\/j.prp.2024.155231_bib147","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.annonc.2019.10.013","article-title":"Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions","volume":"31","author":"Haenssle","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2024.155231_bib148","article-title":"Organoid intelligence: Integration of organoid technology and artificial intelligence in the new era of in vitro models","volume":"21","author":"Shi","year":"2024","journal-title":"Med. Nov. Technol. Devices"},{"key":"10.1016\/j.prp.2024.155231_bib149","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.7150\/thno.87266","article-title":"Organ-on-a-chip meets artificial intelligence in drug evaluation","volume":"13","author":"Deng","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2024.155231_bib150","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41592-022-01508-0","article-title":"Automated high-speed 3D imaging of organoid cultures with multi-scale phenotypic quantification","volume":"19","author":"Beghin","year":"2022","journal-title":"Nat. Methods"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824001420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824001420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T20:26:44Z","timestamp":1718224004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824001420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":150,"alternative-id":["S0344033824001420"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155231","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-derived melanoma models","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"155231"}}